These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2437025)

  • 1. A transposable epitope of HLA-B7, B40 molecules.
    Ways JP; Lawlor DA; Wan AM; Parham P
    Immunogenetics; 1987; 25(5):323-8. PubMed ID: 2437025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of monoclonal antibodies to cell surface molecules. Quantitative analysis of the reactions and cross-reactions of an antibody (MB40.3) with four HLA-B molecules.
    Parham P
    J Biol Chem; 1984 Nov; 259(21):13077-83. PubMed ID: 6333424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary structure of papain-solubilized human histocompatibility antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants.
    López de Castro J; Bragado R; Strong DM; Strominger JL
    Biochemistry; 1983 Aug; 22(16):3961-9. PubMed ID: 6193808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
    Darke C
    Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against two separate alloantigenic sites of HLA-B40.
    Parham P
    Immunogenetics; 1981; 13(6):509-27. PubMed ID: 7026428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies.
    Parham P; Antonelli P; Herzenberg LA; Kipps TJ; Fuller A; Ward FE
    Hum Immunol; 1986 Jan; 15(1):44-67. PubMed ID: 2419285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.
    Toubert A; Raffoux C; Boretto J; Sire J; Sodoyer R; Thurau SR; Amor B; Colombani J; Lemonnier FA; Jordan BR
    J Immunol; 1988 Oct; 141(7):2503-9. PubMed ID: 2459214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition.
    Barbosa JA; Santos-Aguado J; Mentzer SJ; Strominger JL; Burakoff SJ; Biro PA
    J Exp Med; 1987 Nov; 166(5):1329-50. PubMed ID: 2445888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
    Aparicio P; Vega MA; López de Castro JA
    J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
    Parham P
    J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complete primary structure of HLA-Bw58.
    Ways JP; Coppin HL; Parham P
    J Biol Chem; 1985 Oct; 260(22):11924-33. PubMed ID: 2995352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HLA class I specific monoclonal antibody that fails to bind to all HLA-A antigens.
    Ellis SA; Taylor C; Hildreth JE; McMichael AJ
    Hum Immunol; 1985 May; 13(1):13-9. PubMed ID: 2580818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of HLA-B40 epitopes.
    Kawaguchi G; Kato N; Kashiwase K; Karaki S; Kohsaka T; Akaza T; Kano K; Takiguchi M
    Hum Immunol; 1993 Mar; 36(3):193-8. PubMed ID: 7686546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.
    Hildebrand WH; Madrigal JA; Little AM; Parham P
    J Immunol; 1992 Feb; 148(4):1155-62. PubMed ID: 1737933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HLA-Bw73 by serology and one-dimensional isoelectric focusing patterns.
    Eynon EE; Yang SY; Cronin CR; Alosco SM; Alper CA; Yunis EJ
    Hum Immunol; 1986 Aug; 16(4):356-63. PubMed ID: 2428782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.
    Parham P
    Immunogenetics; 1983; 18(1):1-16. PubMed ID: 6190743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group.
    de Rooij-Doyer E; Schoen MA; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Oct; 18(4):205-16. PubMed ID: 6178176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies.
    McCutcheon JA; Lutz CT
    Hum Immunol; 1992 Oct; 35(2):125-31. PubMed ID: 1283748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel HLA allele, HLA-B*4013, identified from a potential bone marrow recipient. Putative gene conversion events with donor sequence.
    Blanco PV; Theile G; Marcos C; Capucchio M; Lindel N; Sala L; Fainboim L; Satz ML
    Tissue Antigens; 2001 Apr; 57(4):380-3. PubMed ID: 11380953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.